| Bird Of Paradise Psychological Services Pa | |
|
7051 W. Commercial Blvd Suite #3a Tamarac FL 33319-2146 | |
| (954) 720-0412 | |
| (954) 720-0824 |
| Full Name | Bird Of Paradise Psychological Services Pa |
|---|---|
| Speciality | Psychologist |
| Location | 7051 W. Commercial Blvd, Tamarac, Florida |
| Authorized Official Name and Position | Karlin Antoinette Donegal (OWNER, CEO, CFO) |
| Authorized Official Contact | 9547200412 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Bird Of Paradise Psychological Services Pa 7051 W. Commercial Blvd Suite #3a Tamarac FL 33319-2146 Ph: (954) 720-0412 | Bird Of Paradise Psychological Services Pa 7051 W. Commercial Blvd Suite #3a Tamarac FL 33319-2146 Ph: (954) 720-0412 |
| NPI Number | 1184886624 |
|---|---|
| Provider Enumeration Date | 06/26/2008 |
| Last Update Date | 10/02/2014 |
| Medicare PECOS PAC ID | 5496811572 |
|---|---|
| Medicare Enrollment ID | O20090226000228 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.
There has always been controversy surrounding vaccines, but in the past, that was usually overridden by fear of the disease itself. The diseases vaccines prevent can be dangerous or even deadly. However, many anti-vaccination groups add to the confusion of people on the benefits of immunization against infectious diseases.
In a first of its kind clinical trial, Debra Zand, Ph.D., and her team at Saint Louis University, will run an intervention program to help parents address and manage their children's challenging behaviors immediately after being diagnosed with autism.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported second quarter fiscal 2012 revenue of $29.5 million, up 26% compared to revenue of $23.4 million in the same period of fiscal 2011.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184886624 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PY6151 (Florida) | Primary |
| Provider Name | Karlin A Donegal |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1770670549 PECOS PAC ID: 8224194303 Enrollment ID: I20090226000220 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.
There has always been controversy surrounding vaccines, but in the past, that was usually overridden by fear of the disease itself. The diseases vaccines prevent can be dangerous or even deadly. However, many anti-vaccination groups add to the confusion of people on the benefits of immunization against infectious diseases.
In a first of its kind clinical trial, Debra Zand, Ph.D., and her team at Saint Louis University, will run an intervention program to help parents address and manage their children's challenging behaviors immediately after being diagnosed with autism.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported second quarter fiscal 2012 revenue of $29.5 million, up 26% compared to revenue of $23.4 million in the same period of fiscal 2011.
› Verified 7 days ago
| Provider Name | Miriam J Rodriguez |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1619398419 PECOS PAC ID: 2567897101 Enrollment ID: I20200108002911 |
News Archive
Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.
There has always been controversy surrounding vaccines, but in the past, that was usually overridden by fear of the disease itself. The diseases vaccines prevent can be dangerous or even deadly. However, many anti-vaccination groups add to the confusion of people on the benefits of immunization against infectious diseases.
In a first of its kind clinical trial, Debra Zand, Ph.D., and her team at Saint Louis University, will run an intervention program to help parents address and manage their children's challenging behaviors immediately after being diagnosed with autism.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported second quarter fiscal 2012 revenue of $29.5 million, up 26% compared to revenue of $23.4 million in the same period of fiscal 2011.
› Verified 7 days ago
News Archive
Alexza Pharmaceuticals, Inc. announced today that it completed an End-of-Review meeting with the U.S. Food and Drug Administration (FDA or Agency) for the AZ-004 New Drug Application (NDA), and has received the official FDA minutes from the meeting. In December 2010, Alexza held the End-of-Review meeting in response to a Complete Response Letter (CRL) received in October 2010.
There has always been controversy surrounding vaccines, but in the past, that was usually overridden by fear of the disease itself. The diseases vaccines prevent can be dangerous or even deadly. However, many anti-vaccination groups add to the confusion of people on the benefits of immunization against infectious diseases.
In a first of its kind clinical trial, Debra Zand, Ph.D., and her team at Saint Louis University, will run an intervention program to help parents address and manage their children's challenging behaviors immediately after being diagnosed with autism.
Abiomed, Inc., a leading provider of breakthrough heart support technologies, today reported second quarter fiscal 2012 revenue of $29.5 million, up 26% compared to revenue of $23.4 million in the same period of fiscal 2011.
› Verified 7 days ago
Psychiatry Group & Behavioral Associates Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7310 W Mcnab Rd Ste 103, Tamarac, FL 33321 Phone: 786-306-5035 | |
Sna Psychiatry Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7875 Nw 57th St Unit 25537, Tamarac, FL 33320 Phone: 754-229-9434 | |
Destination Hope Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 8301 W Mcnab Rd, Tamarac, FL 33321 Phone: 954-771-2091 | |
Transforming Lives, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 8000 Nw 100th Way, Tamarac, FL 33321 Phone: 954-547-3696 Fax: 954-720-9874 | |
Fruit Of The Spirit Ministry Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 7300 W Mcnab Rd, Tamarac, FL 33321 Phone: 954-200-3409 | |
Go 2 Help Network Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 8976 Lancaster St, Tamarac, FL 33321 Phone: 786-601-2608 Fax: 305-647-0250 | |
Fatima Khan Ali Consultant Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 8050 N University Dr Ste 201, Tamarac, FL 33321 Phone: 954-532-2920 |